Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Eletriptan enters phase III trials

April 24, 1997

No Comments

Yamasa describes cognition-enhancing agents

April 24, 1997

No Comments

Arzneimittelwerk describes new anticonvulsants

April 24, 1997

No Comments

Grape seed proanthocyanidins compared to other antioxidants in vitro and in vivo

April 24, 1997

No Comments

Canadian clearance for Naropin

April 23, 1997

No Comments

Positive clinical results for mitoxantrone in multiple sclerosis

April 23, 1997

No Comments

Piracetam as an adjuvant to language therapy for aphasia

April 23, 1997

No Comments

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

April 23, 1997

No Comments

AutoImmune freezes development of Myloral

April 22, 1997

No Comments

BASF selects dual D4/5-HT2 antagonist for clinical development

April 22, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Neurology/psychiatric
RSS

Eletriptan enters phase III trials

Yamasa describes cognition-enhancing agents

Arzneimittelwerk describes new anticonvulsants

Grape seed proanthocyanidins compared to other antioxidants in vitro and in vivo

Canadian clearance for Naropin

Positive clinical results for mitoxantrone in multiple sclerosis

Piracetam as an adjuvant to language therapy for aphasia

Novel 5-HT uptake inhibitors from Bristol-Myers Squibb

AutoImmune freezes development of Myloral

BASF selects dual D4/5-HT2 antagonist for clinical development

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Neurology/psychiatric RSS

Neurology/psychiatric
RSS